The Federal Court of Canada amended the title of two Canadian patents to add an inventor who was omitted through “inadvertence or mistake” and not for the purposes of delay. Applying well established law, the Court agreed the Applicant’s evidence satisfied its burden. Notably, the Court made the finding without a hearing and based on a written record alone.
Alexion Pharmaceuticals, Inc. v. Canada (Attorney General), 2023 FC 115